AMENDED AND RESTATED AGREEMENT AND PLAN OF MERGER by and among BIOSANTE PHARMACEUTICALS, INC. ANI MERGER SUB, INC. and ANIP ACQUISITION COMPANY Dated as of April 12, 2013Agreement and Plan of Merger • April 12th, 2013 • Biosante Pharmaceuticals Inc • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledApril 12th, 2013 Company Industry JurisdictionThis Amended and Restated Agreement and Plan of Merger, dated as of April 12, 2013 (this “Agreement”), is by and among BioSante Pharmaceuticals, Inc., a Delaware corporation (the “Company”), ANI Merger Sub Inc., a Delaware corporation and a wholly owned subsidiary of the Company (“Merger Sub”) and ANIP Acquisition Company (d/b/a ANI Pharmaceuticals), a Delaware corporation (“ANI”). The Company, Merger Sub and ANI are sometimes referred to in this Agreement as the “Parties”.
AGREEMENT AND PLAN OF MERGER by and between BIOSANTE PHARMACEUTICALS, INC. and ANIP ACQUISITION COMPANY Dated as of October 3, 2012Agreement and Plan of Merger • October 4th, 2012 • Biosante Pharmaceuticals Inc • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledOctober 4th, 2012 Company Industry JurisdictionThis AGREEMENT AND PLAN OF MERGER, dated as of October 3, 2012 (this “Agreement”), is by and between BioSante Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and ANIP Acquisition Company (d/b/a ANI Pharmaceuticals), a Delaware corporation (“ANI”). The Company and ANI are sometimes referred to in this Agreement as the “Parties”.